Addex Therapeutics Ltd. - American Depositary Shares, each representing 120 ordinary shares Ordinary shares (ADXN)

CUSIP: 00654J206

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / American Depositary Shares, each representing 120 ordinary shares Ordinary shares
Shares outstanding
140,714,351
Total 13F shares
159,827
Share change
+52,000
Total reported value
$717,026
Price per share
$6.05
Number of holders
3
Value change
+$565,878
Number of buys
2

Quarterly Holders Quick Answers

What is CUSIP 00654J206?
CUSIP 00654J206 identifies ADXN - Addex Therapeutics Ltd. - American Depositary Shares, each representing 120 ordinary shares Ordinary shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Addex Therapeutics Ltd. - American Depositary Shares, each representing 120 ordinary shares Ordinary shares (ADXN) as of Q4 2023

As of 31 Dec 2023, Addex Therapeutics Ltd. - American Depositary Shares, each representing 120 ordinary shares Ordinary shares (ADXN) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 159,827 shares. The largest 3 holders included J. Stern & Co. LLP, ARMISTICE CAPITAL, LLC, and NEA Management Company, LLC. This page lists 3 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.